Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 3, 1997, Pages 331-339

  Sotaniemi, Eero A ^a,b   Arranto, Arno J ^a   Pelkonen, Olavi ^a   Pasanen, Markku ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; PHENAZONE; TESTOSTERONE;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; FEMALE; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER BIOPSY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; AGING; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPYRINE; AREA UNDER CURVE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; SMOKING;

EID: 0030973784     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90166-1     Document Type: Article

References (42)

1. Kato R, Vassanelli P, Frontino G, Cheara E. Variation in the activity of liver microsomal drugmetabolizing enzymes in rats in relation to age. Biochem Pharmacol 1964;13:1037-51.
2. Kamataki T, Maeda K, Shimada M, Kitani K, Nagai T, Kato R. Age-related alterations in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P450 in liver microsomes from male to female rats. J Pharmacol Exp Ther 1985;233:222-8.
3. Loi CM, Vestal RE. Drug metabolism in the elderly. Pharmacol Ther 1988;36:131-49.
4. Durnas C, Loi CM, Cusak BJ. Hepatic drug metabolism and aging. Clin Pharmacokinet 1990;189:359-89.
5. O'Malley K, Crooks J, Duke E, Stevenson IH. Effect of age and sex on human drug metabolism. Br Med J 1971;3:607-9.
6. Abernethy DR, Greenblatt DJ. Impairment of lidocaine clearance in elderly male subjects. J Cardiovasc Pharmacol 1983;5:1093-6.
7. Hust LK, Fleishaker JC, Peters GR, Hardy JD, Wright M, Ward P. Effect of age and gender on tirilazad pharmacokinetics in humans. Clin Pharmacol Ther 1994;55:378-84.
8. James OFW, Rawlins MD, Woodhouse K. Lack of ageing effects on human microsomal monooxygenase enzyme activities and on inactivation pathways for reactive metabolic intermediates. In: Kitani K, editor. Liver and aging, Amsterdam: Elsevier Biomedical Press, 1982:395-406.
9. Woodhouse KW, Mutch E, Williams FW, Rawlins MD, James OFW. The effect of age on pathways of drug metabolism in human liver. Age Ageing 1984;13: 328-34.
10. Wynne HA, Murch E, James OFW, Wright P, Rawlins MD, Woodhouse KW. The effect of age upon the affinity of microsomal monooxygenase enzymes for substrate in human liver. Age Ageing 1988;17: 401-5.
11. George G, Wynne HA, Woodhouse KW. The association of age with the induction of drug-metabolizing enzymes in human monocytes. Age Ageing 1990:19: 364-7.
12. Schmucker DL, Woodhouse KW, Wang RK, Wynne H, James OF, McManus M, et al. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 1990;48: 365-74.
13. O'Mahony MS, Woodhouse KW. Age, environmental factors and drug metabolism. Pharmacol Ther 1994; 61:279-87.
14. Woodhouse KW. Modification of drug metabolism in relation to age in humans [abstract]. Therapie 1995; 50(suppl):25.
15. Schaffner F, Popper H. Cholestasis is the result of hypoactive hypertrophie smooth endoplasmic reticulum in the hepatocyte. Lancet 1969;2:355-9.
16. Sotaniemi EA, Ahlquist J, Pelkonen RO, Pirttiaho H, Luoma PV. Liver parenchymal changes and indices of drug metabolism in alcoholics. Eur J Clin Pharmacol 1977;11:295-303.
17. Sotaniemi EA, Sutinen S, Sutinen S, Arranto AJ, Pelkonen RO. Liver injury in subjects occupational exposure to chemicals in low doses. Acta Med Scand 1982;212:207-15.
18. Sotaniemi EA, Niemelä O, Risteli L, Stenbäck F, Pelkonen RO, Lahtela JT, et al. Fibrotic process and drug metabolism in alcoholic liver disease. Clin Pharmacol Ther 1986;40:46-55.
19. Sotaniemi EA, Rautio A, Lumme P, Arvela P. Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in man. Therapie 1996;51:363-6.
20. Vermeulen A, Stoica T, Verdonck L. The apparent free testosterone concentration: an index of androgenecity. J Clin Endocrinol 1971;33:759-67.
21. Vermeulen A, Rubens R, Verdonck L. Testosterone secretion and metabolism in male senescence. J Clin Endocrinol 1972;34:730-5.
22. Greim H, Schenkman M, Klotzbucher M, Remmer H. The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P450 in the rat. Biochim Biophys Acta 1970;201:20-5.
23. Arranto AJ, Sotaniemi EA. Morphologic alterations in patients with alpha-methyldopa-induced liver damage after short and long-term exposure. Scand J Gastroenterol 1981;16:853-63.
24. Arranto AJ. Histological and morphological studies on xenobiotics induced liver injury [thesis]. Acta Universitatis Ouluensis, Oulu, Finland, 1982. 53 p.
25. Vestal RE, Norris AH, Tobin JD, Cohen BH, Shock NW, Andres R. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Clin Pharmacol Ther 1975;18:425-32.
26. Sotaniemi EA, Pelkonen RO. Drug metabolism in man: in vivo and in vitro correlations. In: Sotaniemi EA, Pelkonen RO, editors. Enzyme induction in man. London: Taylor & Francis, 1987:79-93.
27. Vesell ES. Genetic and environmental factors affecting drug disposition in man. Clin Pharmacol Ther 1977;17:48-56.
28. Kappas A, Anderson KE, Conney AH, Alvares AP. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin Pharmacol Ther 1976;20:643-54.
29. Schmucker DL, Wang RK. Age-related changes in liver drug metabolism: structure vs function. Proc Soc Exp Biol Med 1980;165:178-87.
30. Schmucker DL, Mooney JS, Jones AL. Stereological analysis of hepatic fine structure in the Fischer 344 rat: influence of sublobular location and animal age. J Cell Biol 1978;73:319-37.
31. Schmucker DL, Vessey DA, Wang RK, James J, Maloney A. Age-dependent alterations in the physicochemical properties of rat liver microsomes. Mech Ageing Dev 1984;27:207-17.
32. Engel G, Hoffman U, Heideman H, Cosme J, Eichelbaum M. Antipyrine as a probe for human oxidative drug metabolism; I: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydromethylantopyrine, and norantipyrine formation. Clin Pharmacol Ther 1996;59:613-23.
33. Sharer JE, Wrighton SA. Identification of the human hepatic cytochromes P450 involved in the vitro oxidation of antipyrine. Drug Metab Dispos 1996;24:487-94.
34. Brodie MJ, Boobis AR, Bulpitt CJ, Davies DS. Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. Eur J Clin Pharmacol 1981;20:30-46.
35. Sotaniemi EA, Pirttiaho HI, Stenbäck FG. Drug interaction involving changes in liver size and fibrogenesis. Int J Clin Pharmacol Ther Toxicol 1992;30:523-35.
36. Sherlock S, Beam AG, Billing BH, Paterson JCS. Splanchnic blood flow in man by the bromsulfalein method: the relation of peripheral plasma bromsulfalein level to the calculated flow. J Lab Clin Med 1950;35:923-32.
37. Adir J, Miller AK, Vestal RE. Effects of total plasma concentration and age on tolbutamide plasma protein binding. Clin Pharmacol Ther 1982;31:488-93.
38. Anttila M, Laakso S, Nyländen P, Sotaniemi EA, Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function. Clin Pharmacol Ther 1995;57:628-35.
39. Conney AH. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 1967;19:317-66.
40. Pasanen M, Haaparanta T, Sundin M, Sivonen P, Vähäkangas P, Raunio H, et al. Immunochemical and molecular biological studies P450-dependent monooxygenase activities. Toxicology 1990;62:175-87.
41. Sesardic D, Pasanen M, Pelkonen O, Boobis AR. Differential expression and regulation of members of the cytochrome P450 1A gene subfamily in human tissues. Carcinogenesis 1990;11:1183-8.
42. Pelkonen O, Pasanen M, Kuha H, Gachalyi B, Kairaluoma M, Sotaniemi EA, et al. The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies. Br J Clin Pharmacol 1986;22:125-34.